ﻣﻘﺪﻣﻪ: دﯾﺎﺑﺖ ﯾﮑﯽ از ﺑﯿﻤﺎريﻫﺎي ﻣﺰﻣﻦ ﺷﺎﯾﻊ اﺳﺖ ﮐﻪ ﻋﺪم ﺗﻮﺟﻪ ﺑﻪ آن ﻣﯽﺗﻮاﻧﺪ ﻋﻮارض زﯾﺎدي ﺑﻪ دﻧﺒﺎل داﺷﺘﻪ ﺑﺎﺷﺪ. از اﯾﻦ رو، داﺷﺘﻦ اﻣﯿﺪ، ﺗﺒﻌﯿﺖ از درﻣﺎن و ﮐﻨﺘﺮل ﻗﻨﺪﺧﻮن اﻣﺮي ﺣﯿﺎﺗﯽ ﻣﯽﺑﺎﺷﺪ. اﯾﻦ ﭘﮋوﻫﺶ ﺑﺎ ﻫﺪف ﺗﻌﯿﯿﻦ اﺛﺮﺑﺨﺸﯽ درﻣﺎن ﺷﻨﺎﺧﺘﯽ-رﻓﺘﺎري ﻣﺬﻫﺐﻣﺤﻮر ﺑﺮ ﺗﺒﻌﯿﺖ از درﻣﺎن، اﻣﯿﺪ ﺑﻪ زﻧﺪﮔﯽ و ﻣﯿﺰان ﻫﻤﻮﮔﻠﻮﺑﯿﻦ ﮔﻠﯿﮑﻮزﯾﻠﻪ )HbA1C( ﺑﯿﻤﺎران ﻣﺒﺘﻼ ﺑﻪ دﯾﺎﺑﺖ ﻧﻮع دو
اﻧﺠﺎم ﺷﺪ. ﻣﻮاد و روشﻫﺎ: اﯾﻦ ﻣﻄﺎﻟﻌﻪ از ﻧﻮع ﺷﺒﻪآزﻣﺎﯾﺸﯽ ﺑﺎ ﻃﺮح ﭘﯿﺶآزﻣﻮن و ﭘﺲآزﻣﻮن و ﮔﺮوه ﮐﻨﺘﺮل ﺑﻮد. ﺟﺎﻣﻌﻪ آﻣﺎري ﭘﮋوﻫﺶ، ﮐﻠﯿﻪ ﺑﯿﻤﺎران دﯾﺎﺑﺘﯽ ﻣﺮاﺟﻌﻪﮐﻨﻨﺪه ﺑﻪ ﻣﺮاﮐﺰ ﺧﺪﻣﺎت ﺟﺎﻣﻊ ﺳﻼﻣﺖ ﺷﻬﺮ ﻗﺎﺋﻢﺷﻬﺮ در ﺳﺎل 1399 را ﺷﺎﻣﻞ ﻣﯽﺷﺪ. ﺗﻌﺪاد 30 ﻧﻔﺮ از ﺑﯿﻤﺎران ﺑﺎ روش ﻧﻤﻮﻧﻪﮔﯿﺮي ﻫﺪﻓﻤﻨﺪ اﻧﺘﺨﺎب و ﺑﻪ ﻃﻮر ﺗﺼﺎدﻓﯽ ﺳﺎده )ﻗﺮﻋﻪﮐﺸﯽ( ﺑﻪ دو ﮔﺮوه 15 ﻧﻔﺮه آزﻣﺎﯾﺶ و ﮐﻨﺘﺮل ﺗﻘﺴﯿﻢ ﺷﺪﻧﺪ. ﮔﺮوه آزﻣﺎﯾﺶ 10 ﺟﻠﺴﻪ 60 دﻗﯿﻘﻪاي درﻣﺎن ﺷﻨﺎﺧﺘﯽ رﻓﺘﺎري ﻣﺬﻫﺐﻣﺤﻮر درﯾﺎﻓﺖ ﻧﻤﻮد، اﻣﺎ ﮔﺮوه ﮐﻨﺘﺮل ﻣﺪاﺧﻠﻪ درﯾﺎﻓﺖ
ﻧﮑﺮد. دادهﻫﺎ ﺑﺎ اﺳﺘﻔﺎده از آزﻣﻮن ﺗﺤﻠﯿﻞ ﮐﻮوارﯾﺎﻧﺲ ﭼﻨﺪ ﻣﺘﻐﯿﺮه ﺗﺠﺰﯾﻪ و ﺗﺤﻠﯿﻞ ﺷﺪﻧﺪ. ﯾﺎﻓﺘﻪﻫﺎ: ﺑﯿﻦ دو ﮔﺮوه آزﻣﺎﯾﺶ و ﮐﻨﺘﺮل، ﺑﺎ ﮐﻨﺘﺮل ﭘﯿﺶآزﻣﻮن از ﻟﺤﺎظ ﻣﺘﻐﯿﺮﻫﺎي ﺗﺒﻌﯿﺖ از درﻣﺎن )0/001
چكيده لاتين :
Introduction: Diabetes is one of the most common chronic diseases with many consequences if ignored. Therefore, having hope, following treatment, and controlling blood sugar are vital. This study aims to determine the effectiveness of religion-based cognitive-behavioral therapy on adherence to treatment, hope, and glycosylated hemoglobin (HbA1C) levels in patients with type 2 diabetes.
Materials and Methods: This work was a quasi-experimental study with pre-test and post-test design and a control group. The statistical population was all diabetic patients referred to the comprehensive health service centers of Ghaemshahr in 2020, 30 of whom were selected by purposive sampling; then, they were randomly assigned to two groups of 15 experimental and control. The experimental group received ten 60-minute sessions of religion-based cognitive-behavioral therapy, while the control group did not receive any intervention. Data were analyzed using multivariate analysis of covariance in spss26 software.
Results: The results showed a significant difference between the experimental and control groups with pre-test control in terms of the variables of treatment adherence (F=39.42, p=0.001) and hope (F=37.73, p=0.001), which increased in the experimental group. However, there was no significant difference in HbA1C (p=0.065, F=3.68).
Conclusion: Due to the effectiveness of religion-based cognitive-behavioral therapy in increasing treatment adherence and the life expectancy of patients with type 2 diabetes, this method can be used as a complementary treatment along with medical therapies to improve their physical and mental health.